Calcium channel blockers
Showing 1 - 25 of 3,976
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Long-term Use of CCB and Breast Cancer Risk
Active, not recruiting
- Hypertension,Essential
- Breast Cancer
- Calcium channel blocker
- +5 more
-
Bentley, Western Australia, AustraliaCurtin university
Aug 1, 2023
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
ive Alzheimer's Medicines- Dihydropyridine Calcium Channel
Active, not recruiting
- Hypertension
- Dihydropyridine calcium channel blocker
- Hydrochlorothiazide
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 1, 2022
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers
Recruiting
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
- PCP
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
Hypertension Trial in Beijing, Zoucheng, ShenZhen (Protocol initiate with A, Protocol initiate with C, Protocol initiate with D)
Recruiting
- Hypertension
- Protocol initiate with A
- +2 more
-
Beijing, Henan, China
- +2 more
Apr 14, 2021
Hypertension, Coronary Atherosclerosis Trial in Tokyo (Calcium channel blockers (amlodipine, azelnidipine))
Completed
- Hypertension
- Coronary Atherosclerosis
- Calcium channel blockers (amlodipine, azelnidipine)
-
Tokyo, JapanDepartment of Cardiology, Juntendo University School of Medicine
May 12, 2021
Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)
Completed
- Hypertension
- Anti-hypertensive Medication -
-
Thessaloniki, Greece
- +1 more
Mar 5, 2021
Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,
Terminated
- Raynaud Disease
- +2 more
- Calcium Channel Blockers
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 8, 2020
The Efficacy of Nifedipine in the Management of Preterm Labor
Not yet recruiting
- Preterm Labor
- +5 more
- Nifedipine 10 mg
- (no location specified)
Nov 19, 2020
Angina, Stable Ischemic Heart Disease Trial in United States (Clinician Discretion, Beta blocker, Calcium channel blocker)
Not yet recruiting
- Angina
- Stable Ischemic Heart Disease
- Clinician Discretion
- +2 more
-
Oakland, California
- +4 more
Mar 23, 2023
Vasospasm;Peripheral, Burning, Pain Trial (Verapamil, Nicardipine)
Not yet recruiting
- Vasospasm;Peripheral
- +2 more
- (no location specified)
Nov 21, 2022
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Clinical Parameters on Admission and Medications in Covid-19
Completed
- Covid-19
- ACE Inhibitors and Calcium Channel Blockers
-
Bahcelievler, Istanbul, TurkeyVital Hospital
Jun 4, 2020
Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas
Completed
- Hypoxia
- dihydropyridine calcium channel inhibitors use
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 8, 2022
Atrial Fibrillation Trial in Boston (Beta-blocker strategy, Calcium channel blocker strategy, Physician preference strategy)
Withdrawn
- Atrial Fibrillation
- Beta-blocker strategy
- +2 more
-
Boston, MassachusettsBoston Medical Center MICU
Dec 1, 2021
Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)
Suspended
- Hypertension
- COVID-19
- Thiazide or Thiazide-like diuretics
- +3 more
-
Galway, IrelandUniversity Hospital Galway
Jun 26, 2020
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Calcium Channel Blockers on COGnitive Function in Very Elderly
Completed
- Cognitive Ability, General
- High Blood Pressure
-
Nantwich, Cheshire, United Kingdom
- +6 more
Aug 21, 2019
Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As
Recruiting
- Atrial Fibrillation
- +2 more
- As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
-
Burlington, VermontUniversity of Vermont Medical Center
Feb 28, 2023
Preterm Labor With Preterm Delivery Trial in Egypt (Potassium Channel Opener, Calcium channel blocker)
Recruiting
- Preterm Labor With Preterm Delivery
- Potassium Channel Opener
- Calcium channel blocker
-
Egypt, Alexandria, EgyptManella Fayez Zaki Beshara
Apr 13, 2021
Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of
Recruiting
- Stable Ischemic Heart Disease
- +2 more
- Medical Assessment
- Quality of Life Assessment
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jan 30, 2023
Heart Rate, Coronary Computed Tomography Angiography Trial in Bangkok (Metoprolol tartrate, Ivabradine, Diltiazem)
Recruiting
- Heart Rate
- Coronary Computed Tomography Angiography
- Metoprolol tartrate
- +2 more
-
Bangkok, Bangkoknoi, ThailandDepartment of Internal Medicine, Faculty of Medicine, Siriraj Ho
May 15, 2022
Atrial Fibrillation With Rapid Ventricular Response, Hypotension Trial (Placebo, Calcium)
Not yet recruiting
- Atrial Fibrillation With Rapid Ventricular Response
- Hypotension
- Placebo
- Calcium
- (no location specified)
Jan 11, 2023